Petřík Miloš Ph.D.
Journals
Lasioglossins LLIII affects the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice.
Microbiology and Immunology.
2017,
61(11),
474-481,
ISSN: 0385-5600,
PMID: 28892177,
Developing targeted hybrid imaging probes by chelator scaffolding.
Bioconjugate Chemistry.
2017,
28(6),
1722-1733,
ISSN: 1043-1802,
PMID: 28462989,
Siderophores for molecular imaging applications.
Clinical and Translational Imaging.
2016,
5(1),
15-27,
ISSN: 2281-5872.
PMID: 28138436,
Open positions
Projekt: | Preclinical development of molecular imaging agents |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 2 |
Určeno pro: | Doktorské studium |
Projekt: | Preclinical development of substances for molecular imaging |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 1 |
Určeno pro: | Doktorské studium |
Souhrn: | 1 place in full-time study |
Projekt: | In vivo imaging of 68Ga labelled biomolecules |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 1 |
Určeno pro: | Bakalářské studium |
Projekt: | Radiolabelled siderophores for infection imaging |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 1 |
Určeno pro: | Magisterské studium |
Projekt: | Radiolabelled peptides for cancer imaging |
---|---|
Vedoucí: | Petřík Miloš Ph.D. |
K dispozici: | 1 |
Určeno pro: | Magisterské studium |